Coldstream Capital Management Inc Bausch Health Companies Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 252 shares of BHC stock, worth $1,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
252Holding current value
$1,242% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
278Shares Held
239MCall Options Held
4.02MPut Options Held
8.72M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$171 Million3.8% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$149 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$130 Million12.9% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$64.1 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$57.9 Million0.0% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.78B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...